Evidence map›Paper›PMID 31540331›Full record

ArticleMedicina (Kaunas, Lithuania)2019

Deduction of Novel Genes Potentially Involved in the Effects of Very Low Dose Atropine (0.003%) Treatment on Corneal Epithelial Cells Using Next-Generation Sequencing and Bioinformatics Approaches.

Wei-An Chang, Yu-Ting Hsiao, Hsien-Chung Lin, Shu-Fang Jian, Yi-Jen Chen, Po-Lin Kuo

Open access · goldAbstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. IMI 2021 Yearly Digest.Investigative ophthalmology & visual science · 2021
    Review
  4. Corneal Penetration of Low-Dose Atropine Eye Drops.Journal of clinical medicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Wei-An ChangGraduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Yu-Ting HsiaoGraduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Hsien-Chung LinGraduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Shu-Fang JianGraduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Yi-Jen ChenGraduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan. chernkmu@gmaill.com.
Po-Lin KuoGraduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Kaohsiung Medical University · TW

Funding

Kaohsiung Medical University KMU-DK108003Kaohsiung Medical University Chung-Ho Memorial Hospital KMUHS10701; KMUHS10712; KMUH107-7R14Kaohsiung Medical University Research Center Grant KMU-TC108A04Ministry of Science and Technology, Taiwan MOST 107-2320-B-037-011-MY3; MOST 108-2314-B-037-096
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AtropineComputational BiologyCorneaEpithelial CellsGene Expression ProfilingHigh-Throughput Nucleotide SequencingHumansMicroRNAsMuscarinic AntagonistsMyopiaAtropineMicroRNAsMuscarinic Antagonistsapoptosisatropinebioinformaticscorneal epithelial cellsnext-generation sequencing

Identifiers

PMID31540331
PMCPMC6780702
OpenAlexW2973222693

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.